Diagnostic Value of Serum Amylase Levels Indicating Computed Tomography-Defined Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Multicenter Observational Study.


Journal

Pancreas
ISSN: 1536-4828
Titre abrégé: Pancreas
Pays: United States
ID NLM: 8608542

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 14 7 2020
medline: 3 8 2021
entrez: 14 7 2020
Statut: ppublish

Résumé

Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis involves persistent serum amylase levels of 3 times or more the standard upper limit. However, these criteria were mostly based on retrospective studies and not necessarily supported by diagnostic imaging. Our prospective study aimed to investigate cutoff serum amylase levels suggesting post-ERCP pancreatitis using computed tomography as the criterion standard. We prospectively followed 2078 cases. Computed tomography was performed in patients whose serum amylase levels exceeded the institutional upper limit 12 to 24 hours after ERCP. Two expert radiologists blindly assessed the images and judged the presence or absence of pancreatitis. Correlations between serum amylase levels with pancreatitis were investigated using receiver operating characteristic analysis. Amylase levels increased in 416 (23.2%) of 1789 cases included, and 350 cases were analyzed using computed tomography. Post-endoscopic retrograde cholangiopancreatography pancreatitis was diagnosed in 12.0% (214/1789). The cutoff amylase levels for judging pancreatitis after 12 to 24 hours was 2.75 times higher than the institutional upper limit, with an area under the curve of 0.77. The appropriate cutoff serum amylase level for judging post-ERCP pancreatitis at 12 to 24 hours after ERCP was 2.75 times higher than the institutional upper limit. These results may clarify the definition of post-ERCP pancreatitis.

Identifiants

pubmed: 32658080
doi: 10.1097/MPA.0000000000001606
pii: 00006676-202008000-00013
doi:

Substances chimiques

Amylases EC 3.2.1.-

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

955-959

Commentaires et corrections

Type : CommentIn

Références

Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81:143–149.e9.
Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80–88.
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–111.
Malfertheiner P, Kemmer TP. Clinical picture and diagnosis of acute pancreatitis. Hepatogastroenterology. 1991;38:97–100.
Dawra R, Sharif R, Phillips P, et al. Development of a new mouse model of acute pancreatitis induced by administration of L-arginine. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1009–G1018.
Agarwal N, Pitchumoni CS, Sivaprasad AV. Evaluating tests for acute pancreatitis. Am J Gastroenterol. 1990;85:356–366.
Rompianesi G, Hann A, Komolafe O, et al. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev. 2017;4:CD012010.
Abid GH, Siriwardana HP, Holt A, et al. Mild ERCP-induced and non-ERCP-related acute pancreatitis: two distinct clinical entities? J Gastroenterol. 2007;42:146–151.
Testoni PA, Vailati C, Giussani A, et al. ERCP-induced and non-ERCP-induced acute pancreatitis: two distinct clinical entities with different outcomes in mild and severe form? Dig Liver Dis. 2010;42:567–570.
Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.
Artifon EL, Chu A, Freeman M, et al. A comparison of the consensus and clinical definitions of pancreatitis with a proposal to redefine post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2010;39:530–535.
Uchino R, Sasahira N, Isayama H, et al. Detection of painless pancreatitis by computed tomography in patients with post-endoscopic retrograde cholangiopancreatography hyperamylasemia. Pancreatology. 2014;14:17–20.
Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174:331–336.
Luiten EJ, Hop WC, Lange JF, et al. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57–65.
Bollen TL, Singh VK, Maurer R, et al. A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol. 2012;107:612–619.
Testoni PA, Mariani A, Giussani A, et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol. 2010;105:1753–1761.
Lankisch PG, Weber-Dany B, Maisonneuve P, et al. Frequency and severity of acute pancreatitis in chronic dialysis patients. Nephrol Dial Transplant. 2008;23:1401–1405.
Harshit Kumar A, Singh Griwan M. A comparison of APACHE II, BISAP, Ranson's score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta classification. Gastroenterol Rep (Oxf). 2018;6:127–131.
Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104:31–40.
Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–918.
Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102:1781–1788.
Katsinelos P, Paroutoglou G, Kountouras J, et al. A comparative study of standard ERCP catheter and hydrophilic guide wire in the selective cannulation of the common bile duct. Endoscopy. 2008;40:302–307.
Read G, Braganza JM, Howat HT. Pancreatitis—a retrospective study. Gut. 1976;17:945–952.
Ito K, Fujita N, Noda Y, et al. Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure. World J Gastroenterol. 2007;13:3855–3860.
Tsujikawa T, Bamba S, Inatomi O, et al. Factors affecting pancreatic hyperamylasemia in patients undergoing peroral single-balloon enteroscopy. Dig Endosc. 2015;27:674–678.

Auteurs

Osamu Inatomi (O)

From the Division of Gastroenterology, Department of Medicine.

Shigeki Bamba (S)

Division of Clinical Nutrition, Shiga University of Medical Science, Otsu.

Yoshitaka Nakai (Y)

Department of Gastroenterology and Hepatology, Kyoto Katsura Hospital.

Kiyonori Kusumoto (K)

Department of Gastroenterology and Hepatology, Kyoto Katsura Hospital.

Takumi Kawakami (T)

Department of Gastroenterology, Kyoto First Red Cross Hospital.

Takahiro Suzuki (T)

Department of Gastroenterology, Kyoto First Red Cross Hospital.

Azumi Suzuki (A)

Department of Gastroenterology, Kyoto Second Red Cross Hospital.

Bunji Endoh (B)

Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto.

Shinichi Ota (S)

Department of Radiology, Shiga University of Medical Science, Otsu, Japan.

Akitoshi Inoue (A)

Department of Radiology, Shiga University of Medical Science, Otsu, Japan.

Yoshio Itokawa (Y)

Department of Gastroenterology and Hepatology, Kyoto Katsura Hospital.

Koki Chikugo (K)

Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto.

Akira Andoh (A)

From the Division of Gastroenterology, Department of Medicine.

Yoshinori Mizumoto (Y)

Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto.

Kiyohito Tanaka (K)

Department of Gastroenterology, Kyoto Second Red Cross Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH